Members follow the same grouping used by the rotation radar, so this page is rebuilt as data updates.
This group currently tracks 4 ETFs, with average boundary fit 65.5% and average structure score 0.66.
Use this page as a filter, then verify single-ETF detail pages.
Biotech / Genomics is still one of the strongest groups, but it is already extended above L4 across many members, so read it as profit-taking and pullback management first.
Participation · Breakout Share 50.0% · Average Fit 65.5%
Start with higher-ranked ETFs, then verify boundary details.
| Group | Participation | Breakout | Trend Score | Structure Fit | Stage |
|---|---|---|---|---|---|
| Cybersecurity | 100.0% | 100.0% | 0.96 | 84.8% | Mainline Expansion |
| Cloud / Software / Internet | 100.0% | 100.0% | 0.94 | 78.7% | Mainline Expansion |
| AI / Robotics | 100.0% | 89.0% | 0.93 | 73.8% | Mainline Expansion |
| Nuclear / Uranium | 100.0% | 100.0% | 0.93 | 67.7% | Mainline Expansion |
| Silver | 100.0% | 100.0% | 0.93 | 67.3% | Mainline Expansion |
| Gold Miners | 100.0% | 100.0% | 0.92 | 67.3% | Mainline Expansion |
| Physical Gold | 100.0% | 100.0% | 0.92 | 65.3% | Mainline Expansion |
| Defense / Aerospace | 100.0% | 86.0% | 0.89 | 72.5% | Mainline Expansion |
| Ticker | Name | Trend | Stage | Target Room | Historical Fit | Rank | Why Leading |
|---|---|---|---|---|---|---|---|
| ARKG | ARK Genomic Revolution ETF | strong bullish zone | L4+ | 1.7% | 62.5% | 1/4 | Above L4, strongest breakout confirmation |
| IBB | iShares Biotechnology ETF | bullish-leaning zone | L1-L2 | 1.1% | 62.3% | 2/4 | Above L3 by 0.5%, stronger group position |
| FBT | First Trust NYSE Arca Biotechnolo… | bullish-leaning zone | L1-L2 | 0.1% | 61.4% | 3/4 | Above L3 by 0.0%, stronger group position |
| XBI | State Street SPDR S&P Biotech ETF | neutral zone | L1-L2 | 3.5% | 62.4% | 4/4 | Currently in L1-L2, useful peer benchmark |
Biotech / Genomics is currently in Mainline Expansion; participation is 100.0% and breakout share is 50.0%.
Start with the first ranking card, then verify boundaries, review history and liquidity on the detail page.
Open a single ETF detail page and verify Daily Review, boundary prices, holdings, liquidity and fees.
Use the rotation radar to place this group in the broader market.
Open Rotation Radar ->If the group is weak, compare peers to see where strength is moving.
Back to Research ->| Ticker | Name | Trend | Zone | Lines | Structure Fit | Review | Score |
|---|---|---|---|---|---|---|---|
| ARKG | ARK Genomic Revolution ETF | strong bullish zone | L4+ | 4 | 62.5% | 0.0% | 0.80 |
| IBB | iShares Biotechnology ETF | bullish-leaning zone | L1-L2 | 3 | 62.3% | 0.0% | 0.73 |
| FBT | First Trust NYSE Arca Biotechnolo… | bullish-leaning zone | L1-L2 | 3 | 61.4% | 0.0% | 0.68 |
| XBI | State Street SPDR S&P Biotech ETF | neutral zone | L1-L2 | 2 | 62.4% | 0.0% | 0.68 |
Shows whether the group is only crossing the midline or already stretched far from L3.
Shows how much buffer remains above L1, which helps separate repair from stability.
Shows the average historical boundary review score, a quick read on evidence quality.
| Ticker | Name | Trend | Lines | Zone | Structure Fit | Review | vs L3 | vs L1 | L4 State | Samples |
|---|---|---|---|---|---|---|---|---|---|---|
| ARKG | ARK Genomic Revolution ETF | strong bullish zone | 4 | L4+ | 62.5% | 0.0% | 2.0% | 8.9% | tentative_breakout | 60 |
| IBB | iShares Biotechnology ETF | bullish-leaning zone | 3 | L1-L2 | 62.3% | 50.0% | 0.5% | 3.8% | below trigger | 60 |
| FBT | First Trust NYSE Arca Biotechnolo… | bullish-leaning zone | 3 | L1-L2 | 61.4% | 60.0% | 0.0% | 2.6% | below trigger | 60 |
| XBI | State Street SPDR S&P Biotech ETF | neutral zone | 2 | L1-L2 | 62.4% | 75.0% | -0.2% | 3.1% | below trigger | 60 |
Shows how many historical phase samples this group can replay against.
Shows how often targets were reached in shorter windows, a read on near-term efficiency.
Combines 60D reach rate and average days to target, a read on completion speed.
| Ticker | Name | Review Samples | Hit Rate | Avg Days | L4 15D | L4 30D | L4 60D | Stability | Boundary 20 | Boundary 60 |
|---|---|---|---|---|---|---|---|---|---|---|
| ARKG | ARK Genomic Revolution ETF | 3 | 0.0% | 122.7 | 0.0% | 0.0% | 0.0% | moderate | 22.7 | 23.8 |
| IBB | iShares Biotechnology ETF | 4 | 50.0% | 23.0 | 0.0% | 50.0% | 50.0% | moderate | 25.5 | 26.7 |
| FBT | First Trust NYSE Arca Biotechnolo… | 5 | 60.0% | 17.0 | 20.0% | 40.0% | 60.0% | moderate | 19.7 | 27.8 |
| XBI | State Street SPDR S&P Biotech ETF | 4 | 75.0% | 26.7 | 0.0% | 50.0% | 75.0% | moderate | 26.6 | 31.4 |
| Ticker | Name | Close | L2 | L3 | L4 | Position |
|---|---|---|---|---|---|---|
| ARKG | ARK Genomic Revolution ETF | 44.32 | 42.55 | 43.45 | 44.20 | L4+ |
| IBB | iShares Biotechnology ETF | 198.94 | 195.84 | 197.86 | 200.58 | L1-L2 |
| FBT | First Trust NYSE Arca Biotechnolo… | 256.07 | 254.06 | 256.06 | 261.51 | L1-L2 |
| XBI | State Street SPDR S&P Biotech ETF | 156.86 | 155.57 | 157.20 | 161.10 | L1-L2 |
Members follow the same grouping used by the rotation radar, so this page is rebuilt as data updates.
Read group breadth and distribution first, then ETF lanes, boundary position and historical fit.
The page explains relative structure inside the group; it does not replace official disclosures or suitability checks.